Miquel Cotaina Recio Email and Phone Number

• Propose, design, promote, and evaluate the implementation of strategies to enhance sustainability and health outcomes• Promote and monitor EPR (Pay for Performance Scheme) and DMA (Maximum Acceptable Cost) schemes• Participate in the design and monitoring of contract indicators and health outcome metrics.• Contribute to the implementation of electronic prescriptions in MHDA (Ambulatory Dispensing Hospital Medication)• Analyze and manage medications in special situations… Show more • Propose, design, promote, and evaluate the implementation of strategies to enhance sustainability and health outcomes• Promote and monitor EPR (Pay for Performance Scheme) and DMA (Maximum Acceptable Cost) schemes• Participate in the design and monitoring of contract indicators and health outcome metrics.• Contribute to the implementation of electronic prescriptions in MHDA (Ambulatory Dispensing Hospital Medication)• Analyze and manage medications in special situations (MSE)• Control, utilize, and enhance the RPT (Patient and Treatment Record) by optimizing data quality and incorporating new data from providers• Prepare and compile periodic expense reports and dashboards, along with other MHDA indicators• Present reports to providers and ensure the establishment of agreements for clinical management improvement Show less

• Adverse events management• Reporting of safety reports to Health Authorities• Participation in audits and inspections• Development and review of SOPs (Standard Operating Procedures)• Involvement in Risk Management Plan activities• Providing safety information regarding clinical trials • Conduct employee training within the Company

Oncology and Rare Diseases• Data collection and follow-up of spontaneous cases, clinical and observational trials cases, Named Patient Programs cases and ISS (Investigator Sponsored Studies) cases• Reporting SUSARs (Suspected Unexpected Serious Adverse Reactions) to Health Authorities.• Development and review of local SOPs (Standard Operating Procedures) and review of global SOPs.• Signal detection for both global and local products• In-depth understanding of the assigned… Show more Oncology and Rare Diseases• Data collection and follow-up of spontaneous cases, clinical and observational trials cases, Named Patient Programs cases and ISS (Investigator Sponsored Studies) cases• Reporting SUSARs (Suspected Unexpected Serious Adverse Reactions) to Health Authorities.• Development and review of local SOPs (Standard Operating Procedures) and review of global SOPs.• Signal detection for both global and local products• In-depth understanding of the assigned disease area and product• Creation of educational materials• Development and review of SDEAs (Safety Data Exchange Agreements)• Reconciliation with various vendors for pharmacovigilance, medical review, and digital projects• Participation in the Operational Study Committee along with the Clinical Trials, Quality, Regulatory, and Medical Affairs Units• CAPA (Corrective and Preventive Action) management at local level for pharmacovigilance. Also, handling Global CAPAs related to EMA case reporting• Providing training to newcomers and employees on pharmacovigilance obligations Show less

Multiple Sclerosis and Nervous System Disorders